Stock Screener App

Frei -

Installieren

4.54

1.17% -0.04

Arbutus Biopharma Corp (ABUS)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Finanzdaten der Arbutus Biopharma Corp-Aktie (ABUS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	508.79% 10.74	1.764	1.574	1.339	1.726
Operating Expenses	66.31% 9.251	27.46	15.51	22.78	23.31
Benefits Costs and Expenses	-	-	-	-	-
Costs And Expenses	66.31% 9.251	27.46	15.51	22.78	23.31
Operating Income/Loss	105.79% 1.488	-25.70	-13.93	-21.44	-21.58
Nonoperating Income/Loss	11.76% 1.035	1.173	1.401	1.723	1.787
Income/Loss From Continuing Operations Before Tax	143.79% 10.74	-24.53	1.574	1.339	-19.80
Income/Loss From Continuing Operations After Tax	110.29% 2.523	-24.53	-12.53	-19.72	-19.80
Net Income/Loss	110.29% 2.523	-24.53	-12.53	-19.72	-19.80
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.44% 191.55	190.71	1.3641	189.00	188.04
Diluted Average Shares	0.89% 192.40	190.71	-367.06	189.00	188.04
Basic Earnings Per Share	107.69% 0.01	-0.13	-0.07	-0.10	-0.11
Diluted Earnings Per Share	107.69% 0.01	-0.13	-0.07	-0.10	-0.11
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$37.41

0.51%

GMAB

$28.83

0.42%

INCY

$100.47

1.20%

BNTX

$103.85

0.08%

ONC

$310.01

0.52%

INSM

$184.61

0.50%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters